Comparing the cost-effectiveness of linezolid to trimethoprim/sulfamethoxazole plus rifampicin for the treatment of methicillin-resistant Staphylococcus aureus infection: a healthcare system perspective
| Autor: | von Dach, E., Morel, C.M., Murthy, A., Pagani, L., Macedo-Vinas, M., Olearo, F., Harbarth, S. |
|---|---|
| Zdroj: | In Clinical Microbiology and Infection September 2017 23(9):659-666 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|